Health workers face hidden exposure to cancer-linked hazards
View as a Web Page
News Medical
 
  Oncology Oncology logo  
  The latest oncology news from News Medical  
 Gut changes linger years after polyp removal and may signal colorectal cancer riskGut changes linger years after polyp removal and may signal colorectal cancer risk
 
Researchers found that women who had undergone colorectal adenoma resection still showed gut microbiome and fecal metabolome alterations an average of about 12 years later. These persistent changes partly resembled colorectal cancer-associated patterns, suggesting that the host-microbiome axis may remain altered along the adenoma-cancer continuum.
 
 
 Health workers face hidden exposure to cancer-linked hazardsHealth workers face hidden exposure to cancer-linked hazards
 
A study reveals high exposure to cancer risk factors among health and social care workers in Europe, underscoring the need for enhanced protective measures.
 
   Gene test helps many breast cancer patients avoid chemotherapyGene test helps many breast cancer patients avoid chemotherapy
 
Many people with breast cancer can safely avoid chemotherapy with the use of a gene test, potentially sparing them unnecessary side effects without increasing the risk of the cancer returning, a large international clinical trial led by UCL has found.
 
   Daraxonrasib significantly extends survival in metastatic pancreatic cancerDaraxonrasib significantly extends survival in metastatic pancreatic cancer
 
At the ASCO annual meeting, Dana-Farber's Brian Wolpin, MD, MPH, will present positive results from the RASolute 302 trial showing a substantial prolongation of survival for patients with previously treated metastatic pancreatic cancer, regardless of RAS mutation status, taking daraxonrasib, an investigational oral RAS(ON) multi-selective inhibitor, compared with chemotherapy.
 
   Mesenchymal drift may explain how aging cells lose their identityMesenchymal drift may explain how aging cells lose their identity
 
Mesenchymal drift may help explain how cells lose stable identity and acquire pro-fibrotic, inflammatory mesenchymal traits during aging. The review proposes MD as a unifying framework that links multiple hallmarks of aging and highlights partial reprogramming as a potential, but still preclinical, way to counteract this process.
 
 New AI model predicts cancer treatment responses from mutations
 
Researchers at University of California San Diego have developed a new artificial intelligence (AI) model that can translate a tumor's complex genetic profile into predictions about how that cancer may respond to treatment.
 
 
 Implanted collagen tiles double survival for brain metastasis patients
 
Implanted collagen tiles double survival for brain metastasis patientsA multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center has found that implanting collagen tiles during brain surgery to deliver targeted radiation therapy dramatically improved tumor control, lowered the risk of recurrence and improved overall survival compared to current standard of care for patients with newly diagnosed brain metastases in need of surgical resection.
 
 
 Tobacco price cap could raise billions and improve public health
 
Tobacco price cap could raise billions and improve public healthThe UK could raise up to £4.9 billion over five years and significantly improve public health by capping tobacco prices and increasing taxes.
 
 
 Virtual AI mouse tests nanomedicine without using living animals
 
Virtual AI mouse tests nanomedicine without using living animalsWhen a tumor manages to nestle itself in the brain of a living being, it has - from the tumor's perspective - done something particularly clever.
 
 
 Common anemia drugs may help slow cancer growth and progression
 
Common anemia drugs may help slow cancer growth and progressionCommon medications used to treat anemia may also slow down cancer cell growth, according to new research from Finland.
 
 
 New study tests vitamin D analog against pancreatic cancer
 
New study tests vitamin D analog against pancreatic cancerA small clinical trial led by Dana-Farber Cancer Institute researchers put a Salk Institute idea to the test in patients: that activating the vitamin D receptor can help reshape the protective environment surrounding pancreatic tumors in ways that could make the notoriously difficult-to-treat cancer more vulnerable to therapeutic treatments.
 
 
 Degrading mutant KRAS protein induces greater lung cancer regression
 
Degrading mutant KRAS protein induces greater lung cancer regressionKRAS is one of the oncogenes most frequently altered in cancer, mutated in approximately one-third of lung adenocarcinomas.
 
 
 New PET imaging tracks tumor progression and cardiac inflammation during cancer therapy
 
New PET imaging tracks tumor progression and cardiac inflammation during cancer therapyA novel PET imaging approach enables simultaneous visualization of tumor progression and cardiac inflammatory responses during cancer treatment.
 
 
 PSMA PET detects high-risk prostate cancer bone metastases
 
PSMA PET detects high-risk prostate cancer bone metastasesCompared to conventional imaging techniques, prostate specific membrane antigen (PSMA) PET imaging provides superior detection of bone metastases in prostate cancer patients a critical indicator of a patient's long-term survival.
 
 
 High-risk prostate cancer patients benefit from perioperative apalutamide therapy
 
High-risk prostate cancer patients benefit from perioperative apalutamide therapyHigh-risk localized and locally advanced prostate cancer patients treated with apalutamide - a next generation neoadjuvant androgen-receptor pathway inhibitor (ARPI) - plus hormone therapy before and after prostate cancer surgery resulted in more major pathologic responses and reduced the risk of metastasis or death, meeting both primary endpoints, in an international phase 3 clinical trial led by principal investigator Mary-Ellen Taplin, MD,...
 
 
 New T-cell engager therapy shows effectiveness in advanced solid tumors
 
New T-cell engager therapy shows effectiveness in advanced solid tumorsA team led by researchers from the National Center for Tumor Diseases (NCT/UCC) Dresden at the Carl Gustav Carus University Hospital (UKD) and the Carl Gustav Carus Faculty of Medicine at the TUD Dresden University of Technology will present clinical results for the first time on May 31, 2026, at this year’s annual meeting of the American Society of Clinical Oncology (ASCO) regarding a new cancer immunotherapy for the treatment of advanced tumors.
 
 
 Nerve freezing technique reduces pain after surgical repair for microtia
 
Nerve freezing technique reduces pain after surgical repair for microtiaAnn & Robert H. Lurie Children's Hospital of Chicago is the first in the world to eliminate months of pain after surgical repair for microtia – a rare condition where a child is born with underdeveloped or missing outer ear.
 
 
 Lung cancer cells change identity to resist medical treatments
 
Lung cancer cells change identity to resist medical treatmentsCancer scientists have discovered that lung cancer cells can change their identity to resist treatment.
 
 
 Pembrolizumab combination therapy improves survival in recurrent endometrial cancer patients
 
Pembrolizumab combination therapy improves survival in recurrent endometrial cancer patientsPreviously, immature overall survival results of the NRG Oncology GY018 (NRG-GY018) trial suggested that the use of the immunotherapy drug pembrolizumab in combination with chemotherapy improved overall survival for patients with advanced stage or recurrent endometrial cancer when compared to chemotherapy alone.
 
 
 AI-powered atlas maps immune structures across multiple cancer types
 
AI-powered atlas maps immune structures across multiple cancer typesIn a new study published today in Science, researchers from The University of Texas MD Anderson Cancer Center developed a spatial atlas of specialized immune structures, called tertiary lymphoid structures (TLSs), across multiple cancer types.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026